ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coinbase
COIN
|
+$1.46B |
| 2 |
UiPath
PATH
|
+$871M |
| 3 |
DraftKings
DKNG
|
+$488M |
| 4 |
Unity
U
|
+$365M |
| 5 |
Twilio
TWLO
|
+$342M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$890M |
| 2 |
XYZ
Block Inc
XYZ
|
+$682M |
| 3 |
Intercontinental Exchange
ICE
|
+$549M |
| 4 |
LendingTree
TREE
|
+$362M |
| 5 |
Synopsys
SNPS
|
+$350M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.54% |
| 2 | Technology | 26.75% |
| 3 | Communication Services | 14.55% |
| 4 | Consumer Discretionary | 12.36% |
| 5 | Financials | 3.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fate Therapeutics
FATE
$326M
| $649M | 1.21% |
7,483,102
+928,556
| +14% | +$74.8M |
|
27
Iridium Communications
IRDM
$5.29B
| $544M | 1.01% |
13,592,982
+3,237,835
| +31% | +$126M |
|
|
FIRY
28
Firy Inc
FIRY
$163M
| $534M | 0.99% |
1,230,194
+929,581
| +309% | +$332M |
|
29
JD.com
JD
$44.5B
| $501M | 0.93% |
6,274,717
+1,622,972
| +35% | +$122M |
|
30
Iovance Biotherapeutics
IOVA
$2.83B
| $480M | 0.89% |
18,450,713
-1,275,937
| -6% | -$33.2M |
|
|
TSP
31
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $461M | 0.86% |
+6,472,735
| New | +$278M |
|
32
Trimble
TRMB
$13.9B
| $430M | 0.8% |
5,258,393
+2,448,144
| +87% | +$195M |
|
33
CareDx
CDNA
$2.42B
| $418M | 0.78% |
4,564,110
+103,286
| +2% | +$8.21M |
|
34
Editas Medicine
EDIT
$442M
| $407M | 0.76% |
7,180,055
-1,571,868
| -18% | -$58.1M |
|
35
Regeneron Pharmaceuticals
REGN
$80.8B
| $398M | 0.74% |
713,048
-505,922
| -42% | -$256M |
|
|
TWOU
36
DELISTED
2U Inc
TWOU
| $391M | 0.73% |
312,737
-81,832
| -21% | -$94.5M |
|
37
Teradyne
TER
$59.3B
| $373M | 0.69% |
2,784,316
-92,787
| -3% | -$11.9M |
|
38
PagerDuty
PD
$902M
| $366M | 0.68% |
8,593,607
-1,388,995
| -14% | -$56.3M |
|
39
Vertex Pharmaceuticals
VRTX
$126B
| $358M | 0.67% |
1,774,066
+55,020
| +3% | +$11.5M |
|
40
Ionis Pharmaceuticals
IONS
$9.4B
| $355M | 0.66% |
8,907,733
+3,765,462
| +73% | +$147M |
|
|
CELL
41
DELISTED
PhenomeX Inc. Common Stock
CELL
| $309M | 0.58% |
6,903,209
+1,787,217
| +35% | +$82.8M |
|
|
P
42
Everpure Inc
P
$29.9B
| $298M | 0.55% |
15,254,370
-17,633,366
| -54% | -$347M |
|
|
ACCD
43
DELISTED
Accolade Inc
ACCD
| $294M | 0.55% |
5,417,006
+110,104
| +2% | +$5.35M |
|
44
PayPal
PYPL
$50.5B
| $281M | 0.52% |
965,633
-713,996
| -43% | -$189M |
|
45
Protolabs
PRLB
$2.13B
| $278M | 0.52% |
3,030,630
-624,224
| -17% | -$61.5M |
|
46
KE Holdings
BEKE
$18.8B
| $277M | 0.51% |
5,801,313
-3,790,736
| -40% | -$194M |
|
47
Veeva Systems
VEEV
$37.4B
| $272M | 0.51% |
875,589
+37,081
| +4% | +$10.3M |
|
48
Veracyte
VCYT
$3.8B
| $267M | 0.5% |
6,689,263
-928,024
| -12% | -$39.7M |
|
49
Takeda Pharmaceutical
TAK
$55.7B
| $261M | 0.49% |
15,492,997
-3,224,147
| -17% | -$54.9M |
|
50
Incyte
INCY
$24.4B
| $248M | 0.46% |
2,948,967
-39,182
| -1% | -$3.27M |
|
Similar funds
ARK Investment Management's Q2 2021 Portfolio in Review
As of Q2 2021, ARK Investment Management held 310 positions worth $53.7B, up 6.7% from $50.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
ARK Investment Management's Q2 2021 filing shows 20 new, 111 increased, 152 reduced and 25 closed positions. Its largest new stake was Coinbase: 5,617,415 shares worth $1.42B. The largest sale was Baidu, an estimated $890M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.
- ARK Investment Management's largest Q2 2021 buy was Coinbase: 5,617,415 shares worth $1.42B.
- ARK Investment Management added most to DraftKings in Q2 2021, an estimated $488M increase.
- ARK Investment Management's biggest Q2 2021 reduction was Baidu, cutting an estimated $890M.
- ARK Investment Management fully exited Fastly Inc in Q2 2021, selling an estimated $96.5M.
- ARK Investment Management's ten largest holdings make up 36% of its $53.7B portfolio in Q2 2021.
- ARK Investment Management opened 20 new positions and closed 25 in Q2 2021.
- ARK Investment Management's portfolio value rose 6.7% quarter-over-quarter to $53.7B.
Based on ARK Investment Management's 13F filing for Q2 2021, filed 5 Aug 2021.